Compositions comprising MG29 nucleic acids, polypeptides and associated methods of use

Details for Australian Patent Application No. 2009270826 (hide)

Owner University of Medicine and Dentistry of New Jersey

Inventors Ma, Jianjie; Weisleder, Noah

Agent Shelston IP

Pub. Number AU-B-2009270826

PCT Pub. Number WO2010/009312

Priority 61/212,275 08.04.09 US; 61/135,325 18.07.08 US

Filing date 16 July 2009

Wipo publication date 21 January 2010

Acceptance publication date 4 October 2012

International Classifications

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/009312 Priority application(s): WO2010/009312

4 October 2012 Application Accepted

  Published as AU-B-2009270826

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270830-Stigmine conjugates for substance use disorders

2009270823-Pharmaceutical formulations containing dopamine receptor ligands